230 related articles for article (PubMed ID: 37099933)
41. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
[TBL] [Abstract][Full Text] [Related]
42. Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient.
Lee HK; Morin P; Xia W
Stem Cell Res; 2016 Mar; 16(2):213-5. PubMed ID: 27345971
[TBL] [Abstract][Full Text] [Related]
43. Generation of two lymphoblastoid-derived induced pluripotent stem cell (iPSC) lines from patients with phenylketonuria.
Veleva D; Ay M; Ovchinnikov DA; Prowse ABJ; Menezes MJ; Nafisinia M
Stem Cell Res; 2024 Jun; 77():103407. PubMed ID: 38552357
[TBL] [Abstract][Full Text] [Related]
44. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
45. Generation of three iPSC lines (XACHi007-A, XACHi008-A, XACHi009-A) from a Chinese family with long QT syndrome type 5 with heterozygous c.226G>A (p.D76N) mutation in KCNE1gene.
Zhang Y; Li H; Wang J; Wang G; Tan X; Lei M
Stem Cell Res; 2020 May; 45():101798. PubMed ID: 32344329
[TBL] [Abstract][Full Text] [Related]
46. Generation of human induced pluripotent stem cell line FDCHDPi001-A from a Chinese Han Tourette's syndrome patient.
Yuan A; Tao R; Yu S; Jing N; Sun J
Stem Cell Res; 2021 Apr; 52():102227. PubMed ID: 33607468
[TBL] [Abstract][Full Text] [Related]
47. Generation of two induced pluripotent stem cell lines from two sporadic amyotrophic lateral sclerosis patients.
Wen S; Fu S; Gao C; Lei K; Liu X
Stem Cell Res; 2024 Feb; 74():103288. PubMed ID: 38181637
[TBL] [Abstract][Full Text] [Related]
48. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.
Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP
Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the human induced pluripotent stem cell (iPSC) SZGJMSi004-A line from a 28-year-old Han male patient with depression.
Yin X; Cai Y; Jia N; Hui L; Zhu Z
Stem Cell Res; 2024 Jun; 77():103428. PubMed ID: 38696853
[TBL] [Abstract][Full Text] [Related]
50. Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol.
Zhang Y; Zhu J; Dai Y; Wang L; Liu R; Guo X
Stem Cell Res; 2022 Jul; 62():102788. PubMed ID: 35462158
[TBL] [Abstract][Full Text] [Related]
51. Non-integrating episomal vectors induced pluripotent stem cell line (SDPHi001-A) from a healthy female individual.
Shao J; Shao C; Jin Y; Wang X; Fan H; Yang G
Stem Cell Res; 2021 Oct; 56():102540. PubMed ID: 34547706
[TBL] [Abstract][Full Text] [Related]
52. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
[TBL] [Abstract][Full Text] [Related]
53. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
54. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
55. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
56. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
57. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.
Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB
Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365
[TBL] [Abstract][Full Text] [Related]
58. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
59. Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma.
Chen K; Zhuang Z; Wang Q; Li K; Xu S; Liu M; Zhang K; Wei L; Zhang Y; Lian H; Zhang B; Zhong C
Stem Cell Res; 2021 Oct; 56():102546. PubMed ID: 34587579
[TBL] [Abstract][Full Text] [Related]
60. Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder.
Pugsley K; Namipashaki A; Vlahos K; Furley K; Graham A; Johnson BP; Kallady K; Kuah JY; Mohanakumar Sindhu VP; Suter A; Hawi Z; Bellgrove MA
Stem Cell Res; 2023 Sep; 71():103170. PubMed ID: 37494850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
